Department of Rehabilitation, Academic Medical Center, University of Amsterdam, The Netherlands.
Department of Rehabilitation, Academic Medical Center, University of Amsterdam, The Netherlands.
Gait Posture. 2014 Jul;40(3):391-8. doi: 10.1016/j.gaitpost.2014.05.016. Epub 2014 Jun 4.
In polio survivors with calf muscle weakness, dorsiflexion-restricting ankle-foot orthoses (DR-AFOs) aim to improve gait in order to reduce walking-related problems such as instability or increased energy cost. However, evidence on the efficacy of DR-AFOs in polio survivors is lacking. We investigated the effect of DR-AFOs on gait biomechanics, walking energy cost, speed, and perceived waking ability in this patient group. Sixteen polio survivors with calf muscle weakness underwent 3D-gait analyses to assess gait biomechanics when walking with a DR-AFOs and with shoes only. Ambulant registration of gas-exchange during a 6 min walk test determined walking energy cost, and comfortable gait speed was calculated from the walked distance during this test. Perceived walking ability was assessed using purposely-designed questionnaires. Compared with shoes-only, walking with the DR-AFOs significantly increased forward progression of the center of pressure (CoP) in mid-stance and it reduced ankle dorsiflexion and knee flexion in mid- and terminal stance (p < 0.05). Furthermore, walking energy cost was lower (-7%, p = 0.052) and gait speed was higher (p = 0.005). Patients were significantly more satisfied, felt safer, and less exhausted with the DR-AFO, compared to shoes-only (p < 0.05). DR-AFO effects varied largely across patients. Patients who walked with limited forward CoP progression and persisting knee extension during the shoes-only condition seemed to have benefitted least from the DR-AFO. In polio survivors with calf muscle weakness, DR-AFOs improved gait biomechanics, speed, and perceived walking ability, compared to shoes-only. Effects may depend on the shoes-only gait pattern, therefore further study is needed to determine which patients benefit most from the DR-AFO.
在患有小腿肌无力的脊灰幸存者中,限制背屈的踝足矫形器(DR-AFO)旨在改善步态,以减少与行走相关的问题,如不稳定或增加能量消耗。然而,缺乏关于 DR-AFO 在脊灰幸存者中的疗效证据。我们研究了 DR-AFO 对步态生物力学、行走能量消耗、速度和该患者群体感知行走能力的影响。16 名患有小腿肌无力的脊灰幸存者接受了 3D 步态分析,以评估他们在使用 DR-AFO 和仅穿鞋时的步态生物力学。6 分钟步行测试期间的气体交换的动态记录确定了行走能量消耗,并且从该测试期间的行走距离计算出舒适的行走速度。使用专门设计的问卷评估感知行走能力。与仅穿鞋相比,使用 DR-AFO 行走时,中步的压力中心(CoP)向前推进明显增加,并且它减少了中步和终步的踝关节背屈和膝关节屈曲(p < 0.05)。此外,行走能量消耗降低(-7%,p = 0.052),行走速度提高(p = 0.005)。与仅穿鞋相比,患者对 DR-AFO 的满意度更高,感觉更安全,更不易疲劳(p < 0.05)。DR-AFO 的效果在患者之间差异很大。在仅穿鞋的情况下,CoP 向前推进有限且膝关节持续伸展的患者似乎从 DR-AFO 中获益最小。在患有小腿肌无力的脊灰幸存者中,与仅穿鞋相比,DR-AFO 改善了步态生物力学、速度和感知行走能力。效果可能取决于仅穿鞋的步态模式,因此需要进一步研究以确定哪些患者最受益于 DR-AFO。